LP
ROIV icon

LMR Partners’s Roivant Sciences ROIV Stock Holding History

LMR Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$592K – 1601
2024
Q4 		$592K Sell
50,000
-300,000
-86% -$3.55M 0.01% 806
2024
Q3 		$4.04M Buy
350,000
+300,000
+600% +$3.42M 0.03% 419
2024
Q2 		$529K Buy
50,000
+34,800
+229% +$381K ﹤0.01% 761
2024
Q1 		$160K Buy
+15,200
New +$164K ﹤0.01% 890

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

LMR Partners's ROIV Position: Q2 2026 in Review

LMR Partners increased its Roivant Sciences (ROIV) stake by 108% in Q2 2026, buying an estimated $533K and bringing the position to 34,775 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1010.

LMR Partners first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.7M in Q2 2024. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • LMR Partners held 34,775 shares of Roivant Sciences worth $1.23M as of Q2 2026.
  • LMR Partners bought 18,025 Roivant Sciences shares in Q2 2026, an estimated $533K.
  • Roivant Sciences made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1010 holding.
  • LMR Partners first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • LMR Partners's Roivant Sciences position peaked at $12.7M in Q2 2024.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.